AUS KCI Medical Australia Pty Ltd

Solventum is a healthcare innovation company founded in 2024, when it became an independent business through a spin-off from 3M on April 1st 2024. It operates at the intersection of health, material and data science, developing solutions intended to improve patient outcomes across the continuum of care. The company employs more than 10,000 people worldwide, reports annual sales of approximately $8.3 billion and draws on more than 70 years of delivering healthcare solutions.

Its portfolio is organised into four areas. Medical Solutions covers advanced wound care, surgical solutions, IV site management, sterilisation assurance and patient monitoring technologies. Oral Care comprises dental and orthodontic solutions. Health Information Systems builds on clinical intelligence and data science, while Purification and Filtration supplies technologies for biopharmaceutical, manufacturing and water applications.

The company's technical domains span health science, material science, data science, clinical intelligence, purification and filtration technology, medical device technology and health information systems. It serves industry verticals including healthcare, medical devices, dental and orthodontics, health information technology, biopharmaceutical, manufacturing and water treatment, with operations worldwide.

Work is organised around a patient-centred approach and an interdisciplinary model that combines health, material and data science. The stated mission is to enable better, smarter, safer healthcare, pursued through innovation aimed at the toughest challenges facing healthcare professionals.